To a large extend, increased glucose metabolism in GBM can be plausibly explained through activation of phosphoinositide 3-kinase (PI3K) and Akt via epidermal growth factor receptor (EGFR) gene amplifications and mutations as well as loss of phosphatase and tensin homolog (PTEN) [12]. This evidence concerns the gene EGFR and glioblastoma.